Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Anti-D Rho immunoglobulin - Bharat Serums and Vaccines

Next Previous
Search
Drug Profile

Anti-D Rho immunoglobulin - Bharat Serums and Vaccines

Alternative Names: Anti-D immunoglobulin (monoclonal); Rhoclone

Latest Information Update: 29 Oct 2018

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Bharat Serums and Vaccines
  • Class Antivirals; Immunoglobulins
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Haemolytic disease of newborn

Most Recent Events

  • 11 Oct 2018 Bharat Serum and Vaccines completes a phase II/III trial for Haemolytic disease of newborn (Prevention) in India (IM) (CTRI/2017/03/008101)
  • 30 Mar 2017 Bharat Serums and Vaccines completes a phase III trial for Hemolytic disease of newborn in India (CTRI2015-09-006172) prior to March 2017
  • 15 Mar 2017 Bharat Serum and Vaccines plans a phase II/III trial for Haemolytic disease of newborn (Prevention) in India (CTRI/2017/03/008101)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top